Brilliant Study: Assessing Cognition in Myeloma Patients Undergoing Transplant

The overall objectives in this study are to identify patterns of cognitive impairment pre-
and post-transplant, to assess the similarities of scores of the three cognitive assessments
in myeloma patients who undergo autologous stem cell transplant, and to determine if patients
prefer the self-assessment, Self-Administered Gerocognitive Exam (SAGE) or the healthcare
applied Montreal Cognitive Assessment (MoCA) assessment.

Inclusion Criteria:

- Patients with multiple myeloma

- Patients who will undergo pre-transplant evaluation with intentions to proceed to
autologous stem cell transplant after stem cell collection.

- Patients willing and able to understand and sign an informed consent form

- Patients 18 yrs of age or older

Exclusion Criteria:

- Patients with unstable psychiatric illness within the past 3 months of study
enrollment.

- Patients who are considered unable to perform study evaluations at the investigator's
discretion.

- Patients who are unable to read. (If patients require reading glasses, they must be
worn at time of test.)

- Patients who do not proceed to stem cell transplant within 60 days of stem cell
collection will be excluded from study.

- Patients who receive more than one cycle of chemotherapy between the time of stem cell
collection and transplant will be excluded from study.